Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

API imports in the EU: gauging the FMD’s impact

December 9, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing API, EMA, FMD, Taylor, manufacturing, supply chain

The deaths of dozens of patients as a result of the contaminated heparin incident in 2008 casts a long shadow …
Feature

Savara Pharmaceuticals appoints two board members

December 9, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph McCracken, Pikover, savara

Speciality pharma firm Savara Pharmaceuticals has appointed Dr Joseph McCracken and Yuri Pikover to its board of directors. McCracken has …
Appointment

EMA in new Iclusig probe

December 9, 2013 Sales and Marketing Ariad, EMA, iclusig, leukaemia

Europe’s medicines regulator has begun a new review of Ariad Pharmaceuticals’ leukaemia drug Iclusig, looking in particular at the risk …
News

GSK launches cancer ‘consortium’

December 6, 2013 Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research

GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
News

FleishmanHillard hires senior head from Edelman

December 6, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FleishmanHillard, tolk

Comms and PR global agency FleishmanHillard has appointed Jerry Tolk to be its senior VP, partner and general manager in …
Appointment

NICE wants more Lemtrada data

December 6, 2013 Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …
News

Court annuls EMA data decision

December 5, 2013 Medical Communications, Sales and Marketing AbbVie, EMA, Goldacre, InterMune, alltrials, transparency

The European Court of Justice has annulled interim injunctions against the European Medicines Agency issued earlier this year after AbbVie …
News

New insulin scores for Sanofi

December 5, 2013 Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300

Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …
News

UPDATED: Pfizer first on trial transparency

December 5, 2013 Medical Communications, Sales and Marketing EMA, Goldacre, Pfizer, alltrials, transparency

News

British Safety Council appoints new commercial director

December 5, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BSC, richard evens

Not-for-profit organisation The British Safety Council has appointed Richard Evens as its new commercial director. Evens will be responsible for …
Appointment

Astellas seeks Xtandi extension

December 5, 2013 Sales and Marketing Astellas, Cancer, EU, FDA, US, Xtandi

Astellas Pharma and development partner Medivation are seeking to extend the reach of oncology brand Xtandi by conducting a trial …
News

Pfizer head to be ABPI president

December 4, 2013 Medical Communications, Sales and Marketing ABPI, MSD, PPRS, Pfizer, Whitehead, emms, khanna

The UK managing director of Pfizer Jonathan Emms is to replace Deepak Khanna as the ABPI president from April next …
News

Pfizer expands in Poland

December 4, 2013 Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma

Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …
News

Forest cuts jobs in restructure

December 4, 2013 Research and Development, Sales and Marketing Forest Labs, R&D, US, cuts

Forest Laboratories is restructuring and shedding jobs in a bid to save $500 million in costs by the end of …
News

Prime minister backs GSK in corruption row

December 4, 2013 Medical Communications, Sales and Marketing China, GSK, bribery, david cameron

Prime minister David Cameron has defended London-based pharma giant GlaxoSmithKline over its treatment in China during a visit to the …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026